Article Information
History
- June 9, 2020.
Article Versions
- Version 1 (May 19, 2020 - 02:24).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- B Russell*,1,
- C Moss*,1,
- S Papa2,3,
- S Irshad2,
- P Ross2,
- J Spicer2,3,
- S Kordasti2,4,
- D Crawley1,2,
- H Wylie1,
- F Cahill1,
- A Haire1,
- K Zaki2,
- F Rahman2,
- A Sita-Lumsden2,
- D Josephs1,2,
- D Enting1,2,
- M Lei2,
- S Ghosh2,
- C Harrison2,4,
- A Swampillai2,
- E Sawyer2,3,
- A Dsouza2,
- S Gomberg2,
- P Fields4,
- D Wrench4,
- K Raj4,
- M Gleeson4,
- K Bailey4,
- R Dillon4,
- M Streetley4,
- A Rigg2, PhD,
- R Sullivan3, PhD,
- S Dolly2,** and
- M Van Hemelrijck1,2,**,†, PhD.
- 1King’s College London, School of Cancer and Pharmaceutical Sciences, Translational Oncology and Urology Research (TOUR), London, UK
- 2Guy’s and St Thomas’ NHS Foundation Trust (GSTT), Medical Oncology, London, UK
- 3King’s College London, School of Cancer and Pharmaceutical Sciences, London, UK
- 4Guy’s and St Thomas’ NHS Foundation Trust (GSTT), Haematology Department, London, UK
- ↵Corresponding author:
Mieke Van Hemelrijck, King’s College London – Translational Oncology and Urology Research, GSTT- Guy’s Cancer Real World Evidence Programme, Guy’s Hospital, 3rd Floor Bermondsey Wing, London SE1 9RT, UK, Mieke.vanhemelrijck{at}kcl.ac.uk